SynthesisFrontiers in oncology2025

The efficacy and immune-mediated safety of PD-1/PD-L1 combined with neoadjuvant chemotherapy in triple-negative breast cancer: a meta-analysis.

Xiao Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.